| Stage | CNM | % of rev | CNP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.1B | 100.00% | $2.2B | 100.00% | CNP ×1.02 |
| Gross profit | $573M | 26.71% | $1.3B | 57.33% | CNP +30.6pp |
| Operating income | $227M | 10.58% | $667M | 30.44% | CNP +19.9pp |
| Pre-tax income | $193M | 9.00% | $413M | 18.85% | CNP +9.9pp |
| Net income | $150M | 6.99% | $331M | 15.11% | CNP +8.1pp |
| Stage | CNM | CNP | Gap · A − B |
|---|---|---|---|
| Revenue | $2.1B100.00% | $2.2B100.00% | CNP ×1.02 |
| Gross profit | 26.71%$573M | 57.33%$1.3B | CNP +30.6pp |
| Operating income | 10.58%$227M | 30.44%$667M | CNP +19.9pp |
| Pre-tax income | 9.00%$193M | 18.85%$413M | CNP +9.9pp |
| Net income |
| 6.99%$150M |
| 15.11%$331M |
| CNP +8.1pp |